Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 300 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:23 de febrero. [Ref.ID 103111]
2.Enlace a cita original Cita con resumen
Anónimo. FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture. U.S. Food and Drug Administration 2019:9 de abril. [Ref.ID 103084]
3.Enlace a cita original Cita con resumen
Robertson K, Marshman LAG, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults ith chronic sciatica: a randomized clinical trial. JAMA Neurology 2018:15 de octubre. [Ref.ID 102863]
5. Cita con resumen
Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, for the CHAMP Investigators. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017;376:115-24. [Ref.ID 101371]
6.Enlace a cita original Cita con resumen
Amundsen S, Ovrebo TG, Amble NMS, Poole AC, Nordeng H. Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women. Eur J Clin Pharmacol 2016;72:1525-35. [Ref.ID 101013]
7. Cita con resumen
Muñoz-Ortego J, Solans-Domènech M, Carrion C. Indicaciones médicas de la acupuntura: revisión sistemática. Med Clin (Barc) 2016;147:250-6. [Ref.ID 100723]
9. Cita con resumen
Anónimo. FDA approves Epclusa for treatment of chronic hepatitis C virus infection. U.S. Food and Drug Administration 2016:28 de junio. [Ref.ID 100447]
11.Tiene citas relacionadas Cita con resumen
Anónimo. Zecuity (sumatriptan) migraine patch: Drug Safety Communication - FDA evaluating risk of burns and scars. U.S. Food and Drug Administration 2016:2 de junio. [Ref.ID 100357]
13. Cita con resumen
Anónimo. FDA approves new orphan drug to treat pulmonary arterial hypertension. U.S. Food and Drug Administration 2015:22 de diciembre. [Ref.ID 99740]
14. Cita con resumen
Anónimo. FDA approves Nucala to treat severe asthma. U.S. Food and Drug Administration 2015:4 de noviembre. [Ref.ID 99610]
15. Cita con resumen
Anónimo. FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa. U.S. Food and Drug Administration 2015:16 de octubre. [Ref.ID 99566]
16.Tiene citas relacionadas Cita con resumen
Meltzer EO, Ratner PH, McGraw T. Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study. J Allergy Clin Immunol 2015;3:702-8. [Ref.ID 99480]
17.Enlace a cita original
Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, Sehgal N, Kuester J. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One 2015:14 de julio. [Ref.ID 99455]
18. Cita con resumen
Hawkes N. Modafinil does enhance cognition, review finds. BMJ 2015;351:h4573. [Ref.ID 99412]
19.Tiene citas relacionadas Cita con resumen
Dear JW, Antoine DJ, Park BK. Where are we now with paracetamol?. BMJ 2015;351:h3705. [Ref.ID 99251]
20. Cita con resumen
Anónimo. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. U.S. Food and Drug Administration 2014:1. [Ref.ID 98380]
Seleccionar todas
 
 1 a 20 de 300 siguiente >>